Last reviewed · How we verify
NCT02785315
Cognitive Intervention for Persons With Amnestic Mild Cognitive Impairment
NA trial testing rehabilitation & remediation approach in Mild Cognitive Impairment in 40 participants. Completed in 14 November 2017.
14 November 2017
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 40 |
| Start date | 16 December 2014 |
| Primary completion | 14 November 2017 |
| Estimated completion | 14 November 2017 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- rehabilitation & remediation approach
- remediation approach
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Sponsor
National Taiwan University Hospital
Who can join
50 and older, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
People with mild cognitive impairment (MCI) are at a greater risk of developing dementia. Therefore, it is important to develop effective non-pharmacological interventions to facilitate their cognitive and activities of daily living (ADL) function, which will also prevent or delay their progression to dementia and reduce associated healthcare and social costs. There are currently a variety of cognitive interventions, mainly categorized as remediation and rehabilitation approach. Research to compare their contents and effectiveness is strongly needed. The information can be used to individualize cognitive intervention based on specific cognitive profile of the patient. This study aims to determine the immediate and long-term efficacy of the remediation approach and rehabilitation approach in enhancing the cognitive and ADL function. The research questions include 1) whether the rehabilitation approach compared with the remediation approach has better effects on improving ADL function; (2) whether the remediation approach may only enhance the performance on the cognitive tests rather than on the ADL function. This study will also explore whether the attitudes of caregivers on providing ADL assistance affect effects of cognitive intervention.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Computerised cognitive training for preventing dementia in people with mild cognitive impairment.
Gates NJ, Vernooij RW, Di Nisio M, Karim S, et al · · 2019 · cited 97× · PMID 30864747 · DOI 10.1002/14651858.cd012279.pub2 -
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2020 · cited 53× · PMID 32104914 · DOI 10.1002/14651858.cd012277.pub3 -
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life.
Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2019 · cited 38× · PMID 30864187 · DOI 10.1002/14651858.cd012277.pub2 -
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife.
Gates NJ, Rutjes AW, Di Nisio M, Karim S, et al · · 2019 · cited 25× · PMID 30864746 · DOI 10.1002/14651858.cd012278.pub2
Verify or expand the search:
- PubMed search for NCT02785315
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02785315 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 14 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02785315.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing